REG - CVS Group plc - PDMR Dealing

CVSAnnouncement

28/03/2025 15:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250328:nRSb7563Ca&default-theme=true

RNS Number : 7563C  CVS Group plc  28 March 2025

28 March 2025

 

CVS Group plc

 

("CVS" or the "Company")

 

PDMR Dealing

CVS, the UK's listed veterinary group and a leading provider of veterinary
services, announces that it was notified on 27 March 2025 that a person
closely associated with Richard Gray, Non-executive Director of the Company,
performed a 'Bed and ISA' transfer of 305 ordinary shares of 0.2p each in the
Company ("Ordinary Shares") from their share dealing account to their ISA
account on 26 March 2025.

As a result, Richard Gray's total interest in the Company, including all
persons closely associated, remains at 7,600 Ordinary Shares, representing
0.011% per cent of the total voting rights of the Company.

The notification below, made in accordance with the requirements of the UK
Market Abuse Regulation, provides further detail.

Contacts:

CVS Group
plc
via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

 

Peel Hunt LLP (Nominated Adviser &
Broker)
+44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark / Lalit Bose

 

   Berenberg (Joint
Broker)
+44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

 

Camarco (Financial
PR)

Geoffrey
Pelham-Lane
                     +44 (0)7733 124 226

Ginny
Pulbrook
      +44 (0)7961 315 138

 

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Jennifer Gray

 2    Reason for the notification

 a)   Position/status                                              PCA

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         CVS Group plc

 b)   LEI                                                          213800J41XDQ2NX48O05

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary shares of 0.2 pence each

      Identification code

                                                                   GB00B2863827

 b)   Nature of the transaction                                    On-market purchase

 c)   Price(s) and volume(s)

     Price(s) - pence  Volume(s)

                                                                   Sale      1,007.186         305
                                                                   Purchase  1,008.983         305

 

 d)   Aggregated information

                                                                   Aggregated volume = 305

      - Aggregated volume

                                                                   Aggregated sale price = £3,071.92

      - Price                                                      Aggregated purchase price = £3,077.40

 e)   Date of the transaction                                      26 March 2025

 f)   Place of the transaction                                     London Stock Exchange - AIM (XLON)

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

Aggregated volume = 305

 

Aggregated sale price = £3,071.92

 

Aggregated purchase price = £3,077.40

e)

 

Date of the transaction

 

 

26 March 2025

f)

 

Place of the transaction

 

London Stock Exchange - AIM (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHZVLFLEXLZBBL